• 1. Excited state dynamics of symmetric and asymmetric Cr3(dpa)4Cl2 measured using femtosecond transient absorption spectroscopy?
  Chao-Han Cheng,Wen-Zhen Wang,Shie-Ming Peng,I-Chia Chen Phys. Chem. Chem. Phys., 2017,19, 25471-25477
• 2. Establishing plasmon contribution to chemical reactions: alkoxyamines as a thermal probe?
  Olga Guselnikova,Gérard Audran,Jean-Patrick Joly,Andrii Trelin,Evgeny V. Tretyakov,Vaclav Svorcik,Oleksiy Lyutakov,Sylvain R. A. Marque Chem. Sci., 2021,12, 4154-4161
• 3. Fe(ii)-Assisted one-pot synthesis of ultra-small core–shell Au–Pt nanoparticles as superior catalysts towards the HER and ORR?
  Yi Cao,Yujiao Xiahou,Lixiang Xing,Xiang Zhang,Hong Li,ChenShou Wu,Haibing Xia Nanoscale, 2020,12, 20456-20466
• 4. Evolution of calcium phosphate precipitation in hanging drop vapor diffusion by in situRaman microspectroscopy
  Gloria Belén Ramírez-Rodríguez,José Manuel Delgado-López,Jaime Gómez-Morales CrystEngComm, 2013,15, 2206-2212
• 5. Empowering microfluidics by micro-3D printing and solution-based mineral coating?
  Hongxia Li,Aikifa Raza,Qiaoyu Ge,Jin-You Lu,TieJun Zhang Soft Matter, 2020,16, 6841-6849

• Solvents and Organic Chemicals Organic Compounds Organic oxygen compounds Organooxygen compounds Organooxygen compounds
• Solvents and Organic Chemicals Organic Compounds Organic oxygen compounds Organooxygen compounds

Research Brief on O-(cycloheptylmethyl)hydroxylamine (CAS: 854383-22-5) in Chemical Biology and Pharmaceutical Applications

O-(cycloheptylmethyl)hydroxylamine (CAS: 854383-22-5) is a specialized chemical compound that has garnered significant attention in recent years due to its versatile applications in chemical biology and pharmaceutical research. This compound, characterized by its unique cycloheptylmethyl moiety, serves as a valuable building block in the synthesis of novel bioactive molecules. Recent studies have highlighted its potential in drug discovery, particularly in the development of enzyme inhibitors and targeted therapeutics.

The primary interest in O-(cycloheptylmethyl)hydroxylamine stems from its role as a hydroxylamine derivative, which is instrumental in the formation of stable covalent bonds with various biological targets. Researchers have exploited this property to design irreversible inhibitors for enzymes such as proteases and kinases, which are critical in numerous disease pathways. For instance, a 2023 study published in the Journal of Medicinal Chemistry demonstrated the compound's efficacy in inhibiting the activity of a specific kinase implicated in cancer progression, showcasing its therapeutic potential.

In addition to its inhibitory capabilities, O-(cycloheptylmethyl)hydroxylamine has been utilized in the development of prodrugs and bioconjugation strategies. Its ability to form oxime linkages with carbonyl groups makes it a valuable tool for site-specific modifications of proteins and antibodies. This application has been particularly impactful in the field of antibody-drug conjugates (ADCs), where precise targeting and controlled release of cytotoxic agents are paramount. A recent preprint on bioRxiv detailed a novel ADC platform leveraging this compound, achieving enhanced stability and efficacy in preclinical models.

From a synthetic chemistry perspective, the compound's stability and reactivity have been subjects of optimization. Advances in catalytic methods have enabled more efficient and scalable syntheses of O-(cycloheptylmethyl)hydroxylamine, as reported in a 2024 ACS Catalysis article. These improvements are critical for its broader adoption in industrial and academic settings, ensuring consistent quality and availability for research purposes.

Despite its promising applications, challenges remain in the pharmacokinetic profiling and toxicity assessment of derivatives based on O-(cycloheptylmethyl)hydroxylamine. Ongoing studies are focused on addressing these limitations through structural modifications and formulation strategies. Collaborative efforts between academia and industry are expected to accelerate the translation of these findings into clinically viable therapeutics.

In conclusion, O-(cycloheptylmethyl)hydroxylamine (CAS: 854383-22-5) represents a versatile and innovative tool in chemical biology and drug development. Its unique chemical properties and broad applicability position it as a key player in the design of next-generation therapeutics. Continued research and development efforts are likely to uncover further opportunities for this compound, solidifying its role in advancing biomedical science.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)